期刊文献+

2型糖尿病微血管病变患者血清血小板反应蛋白-1水平的变化及临床意义 被引量:11

Research of serum thrombospondin 1 levels in T2DM patients with microangiopathy complications
原文传递
导出
摘要 目的探讨T2DM微血管病变与血清血小板反应蛋白-1(TSP-1)的相关性。方法将176例研究对象分为糖尿病合并微血管病变组(A,n=58)、未合并微血管病变组(B,n=64)与正常对照组(C,n=54),检测研究对象血清TSP-1水平及相关临床指标,并计算胰岛素抵抗指数(HOMA-IR)、胰岛β细胞功能指数(HOMA-β)。结果 A、B组血清TSP-1水平均高于C组(P<0.05),A组血清TSP-1水平高于B组(P<0.05)。相关分析显示,血清TSP-1水平与FPG、HbA1c、hsC-RP呈正相关(P<0.01),与HOMA-β及FIns呈负相关(P<0.01)。多元线性逐步回归分析显示,HbA1c、FPG、HOMA-β及FIns是血清TSP-1水平的独立影响因素(P<0.05)。结论 TSP-1在T2DM微血管病变患者血清中表达升高,其可能参与糖尿病微血管病变病理生理过程,检测血清TSP-1的水平对预测糖尿病微血管病变有一定的价值。 Objective To explore the relationship of serum thrombospondin -1 (TSP-1) in T2DM patients with microangiopathy complications in T2DM patients . Methods A total of 176 cases were divided into 3 groups: T2DM patients with microangiopathy complications group (group A, 58 cases) , T2DM patientsand without microangiopathy complications group (group B, 64 cases) microangiopathy complications and normal controls group(group C, 54 cases).The serum TSP-1 and other clinical indicators of all the cases were detected .Use The steady -state model was used to account for the indexes of insulin resistance (HOMA- IR) and islet beta cell function index (HOMA-β). Results The serum TSP-1 levels in type 2 diabetes with and without microangiopathy complications were significantly higher in group A and B than those in control group C(P〈0.05). Furthermore, among type 2 diabetes,serum TSP-1 level was higher in patients with microangiopathygroup A than those withoutin group B(P〈0.05). AThe multivariate correlation analysis showed that serum TSP-1 level positively correlates with FBGG, 、HbA1c、hs-C-RP(P〈0.01),while negatively with HOMA-βand FINSns(P〈0.01). Stepwise linear multiple regression revealed that HbA1Cc、FBG、HOMA-βand FINSns (P〈0.05)were the independent factors of serum TSP-1 level(P〈0.05). Conclusion The serum TSP-1 levels is elevated in T2DM patients with microangiopathy,suggesting that it might play a role in the pathophysiology of diabetic microangiopathy,.The serum TSP-1 has and it is significant value in predicting the microangiopathy of theseT2DM patients.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2014年第7期645-648,共4页 Chinese Journal of Diabetes
关键词 血清血小板反应蛋白-1 糖尿病 2型 微血管病变 Thrombospondin 1 (TSP-1) Diabetes mellitus, type 2 Microangiopathy
  • 相关文献

参考文献8

  • 1Wang S, Wu Z, Sorenson CM, et al. Thrombospondin-l-defi eient mice exhibit increased vascular density during retinal vas- cular development and are less sensitive to hyperroxia-mediat- edvessel obliteration, 2003,228 : 630-642.
  • 2Henkin J, Volpert OV. Therapies using anti-angiogenie pep- tide mimetics of thrombospondin-1. Expert Opin Ther Tar gets, 2011,15 : 1369-1386.
  • 3Hohenstein B, Daniel C, Hausknecht B, et al. Correlation of enhanced thrombospondin-1 expression, TGF-beta signaling and proteinuria in human type-2 diabetic nephropathy. Nephrol Dial Transplant, 2008,23 : 3880-3387.
  • 4许琳,刘堃,朱冬青,邬海翔,顾青,许迅.血小板反应蛋白-1在糖尿病大鼠视网膜微血管中的表达[J].上海交通大学学报(医学版),2008,28(6):661-664. 被引量:3
  • 5Williams MD, Nadler JL. Inflammatory mechanisms of diabet iceomplications. Curr Diab Rep, 2007,7 : 242-248.
  • 6Punekar S, Zak S, Kalter VG, et al. Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflamma- tion in a murine model of inflammatory bowel disease. Patho- biology, 2008,75 : 9-21.
  • 7Bonnefoy A, Daenens K, Feys HB, et al. Thrombospondiml controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood, 2006,107: 955-964.
  • 8Olerud J ,Mokhtari D,Johansson M, et al. Thrombospondin-I : an islet endothelialcell signal of importance for β-cell function. Diabetes, 2011,60 : 1946-1954.

二级参考文献12

  • 1Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J]. Cell, 1996, 86 ( 3 ) : 353 - 364.
  • 2Hayes AJ, Li LY, Lippman ME. Science, medicine, and the future. Antivaseular therapy: a new approach to cancer treatment [J]. BMJ, 1999, 318(7187) :853 -855.
  • 3Noor JE, Mitra RS, Sutorik MM, et al. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway[ J]. J Vasc Res, 2000,37(3) :209-218.
  • 4Hiscott P, Paraoan L, Choudhary A, et al. Thrombospondin 1, thrombospondin 2 and the eye[J]. Prog Retin Eye Res, 2006, 25 (1) :1 -18.
  • 5Stenina OI, Krukovets I, Wang K, et al. Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat[J]. Circulation, 2003, 107 (25) :3209 -3215.
  • 6Stenina OI, Krukovets I, Wang K, et al. Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat[ J]. Circulation, 2003, 107(25) :3209 -3215.
  • 7Sheibani N, Sorenson CM, Cornelius LA, et al. Thrombospondin- 1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia [ J]. Biochem Biophys Res Commun, 2000, 267(1 ) :257 -261.
  • 8Wang S, Skorczewski J, Feng X, et al. Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2 [J]. J Biol Chem, 2004,279(33) :34311 -34322.
  • 9Wang S, Wu X, Lincoln TM, et al. Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-beta activity [ J ]. Diabetes, 2003, 52 (8) :2144-2150.
  • 10Wang S, Shiva S, Poczatek MH, et al. Nitric oxide and cGMP dependent protein kinase regulation of glucose-mediated thrombospondin-1 dependent transforming growth factor-beta activation in mesangial ceils [ J ]. J Biol Chem ,2002, 277 ( 12 ) :9880 - 9888.

同被引文献72

引证文献11

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部